U.S. and European severe asthma cohorts: what can they teach us about severe asthma?
about
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung diseaseAltered Innate Immune Responses in Neutrophils from Patients with Well- and Suboptimally Controlled AsthmaBronchodilatory and anti-inflammatory effects of ASM-024, a nicotinic receptor ligand, developed for the treatment of asthmaDisease Burden of Mild Asthma: Findings from a Cross-Sectional Real-World Survey.DNA methylation in the Neuropeptide S Receptor 1 (NPSR1) promoter in relation to asthma and environmental factors.Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.CD11b+ and Sca-1+ Cells Exert the Main Beneficial Effects of Systemically Administered Bone Marrow-Derived Mononuclear Cells in a Murine Model of Mixed Th2/Th17 Allergic Airway Inflammation.Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway.Clinical heterogeneity in the severe asthma research program.Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?Diagnosis of asthma - new theories.Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma.A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma.Frequent exacerbators--a distinct phenotype of severe asthma.Stem-cell extracellular vesicles and lung repair.Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma.Cytokine-Induced Glucocorticoid Resistance from Eosinophil Activation: Protein Phosphatase 5 Modulation of Glucocorticoid Receptor Phosphorylation and Signaling.How should treatment approaches differ depending on the severity of asthma?Association of allergic rhinitis or asthma with pollen and chemical pollutants in Szeged, Hungary, 1999-2007.Severe asthma and allergy: mechanisms, diagnostics and treatment
P2860
Q26786229-345C335D-3C73-47EF-8699-36810122A6F7Q28395377-DE28CCFD-F44A-4BBA-80A9-DD7674CBEE52Q28539013-530E1A8D-3964-47C3-8643-9293A0210319Q33665503-C8BACB58-F746-4410-BAE3-DD54B080E614Q34570967-AAD1619C-FED0-4287-9BA4-C468661CEA09Q36292443-FC039AD2-6287-4761-9584-166009226EDFQ36703006-3BAE2883-0E65-4ED0-946E-2A36EE565006Q37585439-6277A640-268B-4E85-8461-E76E455980A8Q37651783-27C481C3-6F48-4748-9221-73AA2679C0E0Q38116475-53D3B4DE-E8F9-40D3-998C-BDDD5FB2F558Q38283727-950F4356-F03F-432D-A6F7-515FEE4B8107Q38609480-49205FEB-57B0-498D-8549-CB3A61E6E972Q38799654-41EDE484-C6C9-4B1D-9A9C-91DC08A9B3A3Q45031378-A608B0C2-22D9-4CB8-867A-6227D9C98F4DQ45542402-ADAD3D39-C6E8-4B72-B256-7F636874F547Q45790677-E804BEA6-989C-406F-9422-B26B77EC05EFQ47163346-CB167309-9044-4BBC-8257-93F7520435C6Q47915786-A595B6E1-26D4-43D0-88D8-E1E8976662F2Q51533474-40C9851A-0307-4A73-B6E8-B45B658F8024Q57266971-FDEB9E0B-80EC-4B48-8F7D-E102AF27958B
P2860
U.S. and European severe asthma cohorts: what can they teach us about severe asthma?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
U.S. and European severe asthma cohorts: what can they teach us about severe asthma?
@en
type
label
U.S. and European severe asthma cohorts: what can they teach us about severe asthma?
@en
prefLabel
U.S. and European severe asthma cohorts: what can they teach us about severe asthma?
@en
P2860
P1476
U.S. and European severe asthma cohorts: what can they teach us about severe asthma?
@en
P2093
P2860
P304
P356
10.1111/J.1365-2796.2012.02558.X
P407
P577
2012-08-01T00:00:00Z